Boston Scientific is Sued for Patent Infringement & Theft of Trade Secrets on Vascular Stent Graft.NEW YORK New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of -- Shaun Samuels, M.D., an interventional radiologist from Miami, has filed a Complaint for patent infringement patent infringement n. the manufacture and/or use of an invention or improvement for which someone else owns a patent issued by the government, without obtaining permission of the owner of the patent by contract, license or waiver. , trade secret misappropriation misappropriation n. the intentional, illegal use of the property or funds of another person for one's own use or other unauthorized purpose, particularly by a public official, a trustee of a trust, an executor or administrator of a dead person's estate, or by any and unfair competition against the Boston Scientific Corporation in United States District Court United States District Court In the U.S., any of the 94 trial courts of general jurisdiction in the federal judicial system. Each state, as well as the District of Columbia and the Commonwealth of Puerto Rico, has at least one federal district court. in Marshall, Texas. The Complaint alleges that the Boston Scientific/TriVascular Enovus(TM) AAA AAA: see American Automobile Association. (Triple A) A common single-cell battery used in a myriad of electronic devices of all variety. Like its double A (AA) cousin, it provides 1.5 volts of DC power. When used in series, the voltage is multiplied. stent-endograft product infringes Samuels' U.S. Patent No. 6,007,575, entitled "Inflatable Intraluminal Stent And Method For Affixing Same Within The Human Body," and was derived from Samuels' trade secret technology. An endograft is a medical device used to repair abdominal aortic aneurysms (AAA), an abnormal weakening and ballooning of the wall of the main artery of the body. A ruptured AAA usually proves fatal. The device is introduced through an artery in the leg, enabling much safer repair than open surgery and reduced medical costs. The Stanford Group in Houston estimated that the market for AAA endografts could grow to $2.8 billion by 2010. A former bioengineer, Dr. Samuels was a Clinical Assistant Professor at Stanford University and was Chief of Interventional Radiology interventional radiology Imaging A subspecialty of radiology that provides Diagnostic information–eg, CT-guided 'skinny' needle biopsies and dye injection for analysis of various lumina and tracts–eg, arteriography, cholangiography, antegrade at the Palo Alto VA Hospital, and is now a practicing interventional radiologist at a leading endovascular institute in Miami. The patent on Dr. Samuels' first invention was issued in 1995. He currently holds ten medical device patents - six of which are based on inflatable cuff technology - a low-profile design that allows for minimally invasive entry and placement in the vascular system. Two of Dr. Samuels' inflatable cuff patents are directly related to AAA stent graft designs. Dr. Samuels' Complaint further alleges that a key consultant and advisor of Boston Scientific/TriVascular was involved in the misappropriation of proprietary information relating to plans for developing Samuels' endovascular technology. Dr. Samuels is represented in the action by John Sweeney and Harry Marcus of Morgan & Finnegan, LLP LLP - Lower Layer Protocol in New York, an intellectual property law firm; Mikal Watts and Martin Siegel of the Watts Law Firm, LLP in Houston; and Carl Roth and Michael Smith of The Roth Law Firm in Marshall, Texas. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion